norgestrel has been researched along with Insulin Sensitivity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheang, KI; Essah, PA; Nestler, JE; Sharma, S; Wickham, EP | 1 |
Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW | 1 |
Azen, CG; Bergman, RN; Perlman, JA; Roy, S; Watanabe, RM | 1 |
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO | 1 |
Hager, SR; Kalkhoff, RK | 1 |
Godsland, I; Wynn, V | 1 |
Andersen, O; Kühl, C; Saurbrey, N; Skouby, SO | 1 |
4 trial(s) available for norgestrel and Insulin Sensitivity
Article | Year |
---|---|
Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women.
Topics: Academic Medical Centers; Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipoproteins, LDL; Norgestrel; Obesity; Prospective Studies; Thinness; Time Factors; Virginia; Young Adult | 2011 |
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia | 2011 |
Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.
Topics: Adolescent; Adult; B-Lymphocytes; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Metabolic Diseases; Norgestrel; Risk Factors | 1994 |
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.
Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides | 1999 |
3 other study(ies) available for norgestrel and Insulin Sensitivity
Article | Year |
---|---|
Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
Topics: Animals; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Glucose; Hindlimb; Insulin; Insulin Antagonists; Insulin Resistance; Levonorgestrel; Muscles; Norethindrone; Norgestrel; Phenylalanine; Progesterone Congeners; Rats; Rats, Inbred Strains | 1990 |
Effects of oral contraceptives on carbohydrate metabolism.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norethindrone; Norgestrel | 1986 |
Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norgestrel; Pregnancy; Pregnancy in Diabetics | 1987 |